Cidara Therapeutics Inc. (CDTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cidara Therapeutics Inc.

    NASDAQ: CDTX · Real-Time Price · USD
    63.17
    -1.76 (-2.71%)
    At close: Sep 05, 2025, 3:59 PM
    63.89
    1.14%
    After-hours: Sep 05, 2025, 06:13 PM EDT

    Cidara Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.27M 63.91M 64.29M 49.57M
    Cost of Revenue
    		 84.88M 1.52M 143K 189K
    Gross Profit
    		 -83.61M 62.38M 64.14M 49.38M
    Operating Income
    		 -176.1M -24.48M -33.5M -42.26M
    Interest Income
    		 5.81M 2M 191K 212K
    Pretax Income
    		 -170.29M -22.49M -21.71M -42.47M
    Net Income
    		 -169.83M -22.93M -33.58M -42.47M
    Selling & General & Admin
    		 20.61M 18.33M 18.49M 18.74M
    Research & Development
    		 71.88M 68.53M 75.52M 73.09M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 92.49M 86.86M 94.01M 91.83M
    Interest Expense
    		 n/a n/a n/a 212K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 177.38M 88.39M 94.01M 91.83M
    Income Tax Expense
    		 n/a 443K 272K 1.44M
    Shares Outstanding (Basic)
    		 6.35M 4.37M 3.49M 2.62M
    Shares Outstanding (Diluted)
    		 6.35M 4.37M 3.49M 2.62M
    EPS (Basic)
    		 -26.75 -5.25 -9.61 -16.2
    EPS (Diluted)
    		 -26.75 -5.25 -9.61 -16.19
    EBITDA
    		 -176.1M -24.36M -33.36M -42.26M
    EBIT
    		 -176.1M -24.48M -33.31M -42.26M
    Depreciation & Amortization
    		 233K 118K 143K 189K

    Add to Watchlist